News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
286,511 Results
Type
Article (16431)
Company Profile (49)
Press Release (270031)
Section
Business (83759)
Career Advice (1263)
Deals (15574)
Drug Delivery (23)
Drug Development (37376)
Employer Resources (94)
FDA (6414)
Job Trends (6413)
News (142994)
Policy (12231)
Tag
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (3)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (2)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1390)
Accelerated approval (2)
Adcomms (8)
Allergies (36)
Alliances (21415)
ALS (45)
Alzheimer's disease (749)
Antibody-drug conjugate (ADC) (41)
Approvals (6446)
Artificial intelligence (168)
Autoimmune disease (9)
Automation (2)
Bankruptcy (121)
Best Places to Work (5703)
BIOSECURE Act (3)
Biosimilars (36)
Biotechnology (44)
Bladder cancer (38)
Brain cancer (17)
Breast cancer (170)
Cancer (1211)
Cardiovascular disease (72)
Career advice (1057)
Career pathing (21)
CAR-T (58)
Cell therapy (180)
Cervical cancer (16)
Clinical research (30725)
Collaboration (405)
Compensation (73)
Complete response letters (13)
COVID-19 (1226)
CRISPR (11)
C-suite (93)
Cystic fibrosis (47)
Data (1279)
Decentralized trials (2)
Denatured (3)
Depression (22)
Diabetes (120)
Diagnostics (3843)
Digital health (11)
Diversity (3)
Diversity, equity & inclusion (27)
Drug discovery (60)
Drug pricing (15)
Drug shortages (8)
Duchenne muscular dystrophy (36)
Earnings (39987)
Editorial (8)
Employer branding (14)
Employer resources (86)
Events (38313)
Executive appointments (314)
FDA (7045)
Featured Employer (28)
Frontotemporal dementia (4)
Funding (306)
Gene editing (35)
Generative AI (10)
Gene therapy (114)
GLP-1 (250)
Government (1780)
Grass and pollen (1)
Guidances (34)
Healthcare (8289)
Huntington's disease (6)
IgA nephropathy (11)
Immunology and inflammation (43)
Indications (15)
Infectious disease (1298)
Inflammatory bowel disease (90)
Inflation Reduction Act (1)
Influenza (34)
Intellectual property (57)
Interviews (223)
IPO (8303)
IRA (6)
Job creations (977)
Job search strategy (891)
Kidney cancer (6)
Labor market (11)
Layoffs (95)
Leadership (13)
Legal (1949)
Liver cancer (38)
Lung cancer (164)
Lymphoma (66)
Machine learning (3)
Management (33)
Manufacturing (103)
MASH (19)
Medical device (5397)
Medtech (5399)
Mergers & acquisitions (7636)
Metabolic disorders (271)
Multiple sclerosis (49)
NASH (5)
Neurodegenerative disease (30)
Neuropsychiatric disorders (7)
Neuroscience (1012)
NextGen: Class of 2025 (2538)
Non-profit (1673)
Northern California (1320)
Now hiring (2)
Obesity (130)
Opinion (112)
Ovarian cancer (50)
Pain (29)
Pancreatic cancer (59)
Parkinson's disease (79)
Partnered (14)
Patents (115)
Patient recruitment (58)
Peanut (16)
People (19930)
Pharmaceutical (14)
Pharmacy benefit managers (2)
Phase I (9624)
Phase II (13651)
Phase III (10357)
Pipeline (710)
Podcasts (5)
Policy (18)
Postmarket research (1000)
Preclinical (3877)
Press Release (19)
Prostate cancer (47)
Psychedelics (12)
Radiopharmaceuticals (139)
Rare diseases (162)
Real estate (1549)
Recruiting (41)
Regulatory (9425)
Reports (18)
Research institute (1291)
Resumes & cover letters (190)
Rett syndrome (4)
RNA editing (2)
RSV (11)
Schizophrenia (30)
Series A (38)
Series B (35)
Service/supplier (3)
Sickle cell disease (17)
Southern California (1109)
Special edition (10)
Spinal muscular atrophy (68)
Sponsored (17)
Startups (1335)
State (1)
Stomach cancer (5)
Supply chain (19)
Tariffs (1)
The Weekly (2)
United States (11198)
Vaccines (217)
Venture capitalists (12)
Webinars (4)
Weight loss (54)
Women's health (15)
Worklife (8)
Date
Last 7 days (348)
Last 30 days (1398)
Last 365 days (17948)
2025 (4479)
2024 (18849)
2023 (21576)
2022 (27159)
2021 (31011)
2020 (28371)
2019 (20736)
2018 (15287)
2017 (14556)
2016 (12757)
2015 (15237)
2014 (10455)
2013 (7753)
2012 (8183)
2011 (8530)
2010 (7584)
Location
Africa (361)
Alabama (17)
Alaska (3)
Arizona (65)
Arkansas (3)
Asia (16377)
Australia (2758)
California (2899)
Canada (1158)
China (191)
Colorado (164)
Connecticut (163)
Delaware (67)
Europe (37665)
Florida (440)
Georgia (118)
Idaho (64)
Illinois (246)
India (10)
Indiana (131)
Iowa (3)
Japan (84)
Kansas (63)
Kentucky (4)
Louisiana (4)
Maine (55)
Maryland (386)
Massachusetts (2179)
Michigan (127)
Minnesota (184)
Missouri (28)
Montana (10)
Nebraska (11)
Nevada (37)
New Hampshire (38)
New Jersey (894)
New Mexico (10)
New York (923)
North Carolina (437)
North Dakota (2)
Northern California (1320)
Ohio (78)
Oklahoma (3)
Oregon (10)
Pennsylvania (643)
Puerto Rico (5)
Rhode Island (14)
South America (492)
South Carolina (11)
Southern California (1109)
Tennessee (40)
Texas (502)
Utah (85)
Virginia (82)
Washington D.C. (34)
Washington State (281)
West Virginia (1)
Wisconsin (13)
286,511 Results for "prisym id".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Interim analysis of 1-level BAGUERA®C IDE study meets threshold for non-inferiority
March 11, 2025
·
2 min read
Press Releases
Levee Medical Receives FDA Approval for its Landmark ARID II IDE Pivotal Study
March 4, 2025
·
2 min read
Press Releases
Lungpacer Medical Announces Investigational Device Exemption (IDE) for STARI, Phase 2 Feasibility Clinical Trial
March 10, 2025
·
4 min read
Press Releases
Preliminary Results from IDE Study on Ringer™ Perfusion Balloon Catheter (PBC) Reported from Podium at CTO Plus Conference
March 28, 2025
·
4 min read
Press Releases
Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation
March 3, 2025
·
5 min read
Press Releases
Establishment Labs Notes Presentation of 5-Year Results from Motiva U.S. IDE Study at The Aesthetic MEET 2025
March 20, 2025
·
7 min read
Press Releases
IDEAYA Announces Oral Presentation at the New Drugs on the Horizon Series at AACR 2025 for IDE275 (GSK959), a Phase 1 Werner Helicase Inhibitor
March 26, 2025
·
7 min read
Press Releases
bioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/AST system to fight against antimicrobial resistance
March 18, 2025
·
5 min read
Press Releases
Imbed Biosciences Announces FDA IDE Approval for Silver-Gallium Synthetic Antimicrobial Matrix Clinical Study with Human Donor Site Wounds
March 12, 2025
·
3 min read
Press Releases
Newronika Receives Investigational Device Exemption (IDE) from FDA to Initiate U.S. Clinical Trial of Adaptive DBS System
February 5, 2025
·
2 min read
1 of 28,652
Next
